INVESTORS

MC2 Therapeutics is supported by strong investors

MC2 Therapeutics is a privately held company. The primary shareholders are Jørgen M. Clausen (Chairman of Danfoss A/S) and family and Johan Schrøder (formerly Radiometer A/S) and family.

© mc2 therapeutics 2016